Mayo Clinic - Recruiting 18 years or older. - Endovascular Arterial Reperfusion vs. Intravenous ThromboLYsis for Acute Ischemic Stroke (EARLY): A Randomized Pilot Study of Ultra-early (<2 Hours) and Early (2-4.5 Hours) Reperfusion Therapy.
Penumbra Inc. - Recruiting 18 years to 85 years. - The THERAPY Trial: The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke.
intravenous (IV) recombinant human tissue plasminogen activator (rtPA); Penumbra System
China Academy of Chinese Medical Sciences - Recruiting 35 years to 80 years. - Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke With Qi Deficiency and Blood Stasis Syndrome: a Multicenter, Randomized,Double-blind,Placebo- and Active-controlled Adaptive Study.
China Academy of Chinese Medical Sciences - Recruiting 18 years to 70 years. - A Randomized, Multi-center, Double-blind, Placebo-controlled Trial of Danhong Injection in the Treatment of Acute Ischemic Stroke.
Samsung Medical Center - Recruiting N/A or older. - Safety and Efficacy of Therapeutic Induced Hypertension in Patients With Acute Non-cardioembolic Ischemic Stroke: A Multicenter, Randomized, Open Label, Prospective, Phase 3 Study.
Xuanwu Hospital, Beijing - Recruiting 30 years to 80 years. - China Angioplasty & Stenting for Symptomatic Intracranial Severe Stenosis (CASSISS): A Prospective Multi-center, Randomized Controlled Trial (RCT).
Asan Medical Center - Recruiting 40 years or older. - Multicenter Clinical Trial for Development of Guidelines of Adequate Blood Pressure Lowering in the Subacute Ischemic Stroke Patients Due to Intracranial Atherosclerosis.
Aggressive BP lowering; modest blood pressure lowering
Hallym University Medical Center - Recruiting 18 years or older. - Prospective, Randomized, Open-label, Blinded Endpoints, Multi-center Study to Evaluate the Efficacy of Modest Blood Pressure Reduction With Diovanr (Valsartan) in Acute Ischemic Stroke.